Reaction
Metastases To Kidney reporting signals
As of the last recalculation, Metastases To Kidney appears in 546 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is PAZOPANIB HYDROCHLORIDE (PRR 35.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pazopanib Hydrochloride | 24 | 35.3 | 35.3 |
| Gefitinib | 7 | 29.9 | 30.0 |
| Sorafenib | 15 | 28.3 | 28.3 |
| Everolimus | 33 | 26.2 | 26.3 |
| Erlotinib | 6 | 23.9 | 23.9 |
| Ribociclib | 18 | 22.4 | 22.5 |
| Erlotinib Hydrochloride | 7 | 21.6 | 21.6 |
| Osimertinib | 13 | 15.8 | 15.8 |
| Pemetrexed | 8 | 14.4 | 14.4 |
| Palbociclib | 25 | 10.4 | 10.4 |